{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T01:19:51Z","timestamp":1704417591186},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6301","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T22:05:07Z","timestamp":1465941907000},"page":"1599-1603","source":"Crossref","is-referenced-by-count":5,"title":["Urinary \u03b2-2 Microglobulin Levels Sensitively Altered in an Osteomalacia Patient Receiving Add-on Adefovir Dipivoxil Therapy for Hepatitis B Virus Infection"],"prefix":"10.2169","volume":"55","author":[{"given":"Junko","family":"Takagi","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Aichi Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Aichi Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Aichi Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Aichi Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Hirase","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Aichi Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Aichi Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takkan","family":"Morishima","sequence":"additional","affiliation":[{"name":"Division of Orthopedics, Department of Surgery, Aichi Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Otake","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Aichi Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Aichi Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Barditch-Crovo P, Toole J, Hendrix CW, et al. Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients. J Infect Dis 176: 406-413, 1997.","DOI":"10.1086\/514057"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tanji N, Tanji K, Kambham N, Markowitz GS, Bell A, D'agati VD. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol 32: 734-740, 2001.","DOI":"10.1053\/hupa.2001.25586"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45: 804-817, 2005.","DOI":"10.1053\/j.ajkd.2005.02.010"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Marcellin P, Chang TT, Lim SG, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 348: 808-801, 2003.","DOI":"10.1056\/NEJMoa020681"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 348: 800-807, 2003. Erratum in: N Engl J Med 348: 1192, 2003.","DOI":"10.1056\/NEJMoa021812"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Ha NB, Ha NB, Garcia RT, et al. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Hepatology 50: 727-734, 2009.","DOI":"10.1002\/hep.23044"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wu C, Zhang H, Qian Y, Wang L, Gu X, Dai Z. Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition. J Clin Pharm Ther 38: 321-326, 2013.","DOI":"10.1111\/jcpt.12050"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Eguchi H, Tsuruta M, Tani J, Kuwahara R, Hiromatsu Y. Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B. Intern Med 53: 233-237, 2014.","DOI":"10.2169\/internalmedicine.53.1213"},{"key":"9","unstructured":"9. Del Palacio M, Romero S, Casado JL. Proximal tubular renal dysfunction or damage in HIV-infected patients. AIDS Rev 14: 179-187, 2012."},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Hall AM, Bass P, Unwin RJ. Drug-induced renal Fanconi syndrome. QJM 107: 261-269, 2014.","DOI":"10.1093\/qjmed\/hct258"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf) 43: 479-490, 1995.","DOI":"10.1111\/j.1365-2265.1995.tb02621.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dieterle F, Perentes E, Cordier A, et al. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol 28: 463-469, 2010.","DOI":"10.1038\/nbt.1622"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hoffmann D, Fuchs TC, Henzler T, et al. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity. Toxicology 277: 49-58, 2010.","DOI":"10.1016\/j.tox.2010.08.013"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Astor BC, Shaikh S, Chaudhry M. Associations of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rate. Curr Opin Nephrol Hypertens 22: 331-335, 2013.","DOI":"10.1097\/MNH.0b013e32835fe5ad"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Minemura M, Tokimitsu Y, Tajiri K, et al. Development of osteomalacia in a post-liver transplant patient receiving adefovir dipivoxil. World J Hepatol 2: 442-446, 2010.","DOI":"10.4254\/wjh.v2.i12.442"},{"key":"16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5035\/nishiseisai.60.148","volume":"60","author":"Y Kishimoto","year":"2011","unstructured":"16. Kishimoto Y, Okano T, Teshimura R, Toyoshima R. Osteomalacia caused by antiviral drug for chronic hepatitis B: A case report. Orthopedics and Traumatology 60: 148-151, 2011.","journal-title":"Orthopaedics and Traumatology","ISSN":"http:\/\/id.crossref.org\/issn\/0941-2530","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tanaka M, Setoguchi T, Ishidou Y, et al. Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report. Diagn Pathol 7: 108, 2012.","DOI":"10.1186\/1746-1596-7-108"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shimohata H, Sakai S, Ogawa Y, Hirayama K, Kobayashi M. Osteomalacia due to Fanconi's syndrome and renal failure caused by long-term low-dose adefovir dipivoxil. Clin Exp Nephrol 17: 147-148, 2013.","DOI":"10.1007\/s10157-012-0762-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jia HY, Ding F, Chen JY, et al. Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B. World J Gastroenterol 21: 3657-3662, 2015.","DOI":"10.3748\/wjg.v21.i12.3657"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/12\/55_55.6301\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:22:55Z","timestamp":1498321375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/12\/55_55.6301\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6301","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}